Strength training and testosterone treatment have opposing effects on migration inhibitor factor levels in ageing men

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Glintborg, D ^a   Christensen, L L ^a   Kvorning, T ^b   Larsen, R ^c   Brixen, K ^a   Hougaard, D M ^d   Richelsen, B ^e,f   Bruun, J M ^e   Andersen, M ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^d STATENS SERUM INSTITUT   (Denmark)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

^f RANDERS REGIONAL HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MIGRATION INHIBITION FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; PLACEBO; TESTOSTERONE; CCL2 PROTEIN, HUMAN; CCL3 PROTEIN, HUMAN; CHEMOKINE; ISOMERASE; MACROPHAGE MIGRATION INHIBITION FACTOR; MIF PROTEIN, HUMAN;

ADULT; AGED; AGING; ANDROGEN THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FAT MASS; HUMAN; LEAN BODY WEIGHT; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESISTANCE TRAINING; SUBCUTANEOUS FAT; BODY COMPOSITION; CONTROLLED CLINICAL TRIAL; GEL; INFLAMMATION; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTON ABSORPTIOMETRY; TIME; TREATMENT OUTCOME;

ABSORPTIOMETRY, PHOTON; AGED; AGING; BODY COMPOSITION; CHEMOKINE CCL2; CHEMOKINE CCL3; CHEMOKINES; DOUBLE-BLIND METHOD; GELS; HUMANS; INFLAMMATION; INTRAMOLECULAR OXIDOREDUCTASES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RESISTANCE TRAINING; TESTOSTERONE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84884862004     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/539156     Document Type: Article

References (36)

1. Frederiksen L., Højlund K., Hougaard D. M., Brixen K., Andersen M., Testosterone therapy increased muscle mass and lipid oxidation in aging men. Age 2012 34 1 145 156 10.1007/s11357-011-9213-9
2. Dandona P., Dhindsa S., Update: hypogonadotropic hypogonadism in type 2 diabetes and obesity. Journal of Clinical Endocrinology and Metabolism 2011 96 9 2643 2651 2-s2.0-80052530001 10.1210/jc.2010-2724
3. Basaria S., Coviello A. D., Travison T. G., Storer T. W., Farwell W. R., Jette A. M., Eder R., Tennstedt S., Ulloor J., Zhang A., Choong K., Lakshman K. M., Mazer N. A., Miciek R., Krasnoff J., Elmi A., Knapp P. E., Brooks B., Appleman E., Aggarwal S., Bhasin G., Hede-Brierley L., Bhatia A., Collins L., LeBrasseur N., Fiore L. D., Bhasin S., Adverse events associated with testosterone administration. The New England Journal of Medicine 2010 363 2 109 122 2-s2.0-77954421915 10.1056/NEJMoa1000485
4. Frederiksen L., Højlund K., Hougaard D. M., Mosbech T. H., Larsen R., Flyvbjerg A., Frystyk J., Brixen K., Andersen M., Testosterone therapy decreases subcutaneous fat and adiponectin in aging men. European Journal of Endocrinology 2012 166 3 469 476 2-s2.0-84857933573 10.1530/EJE-11-0565
5. Frederiksen L., Glintborg D., Hojlund K., Hougaard D. M., Brixen K., Rasmussen L. M., Andersen M., Osteoprotegerin levels decrease during testosterone therapy in aging men and are associated with changed distribution of regional fat. Hormone and Metabolic Research 2013 45 4 308 313 10.1055/s-0032-1323647
6. Fernández-Balsells M. M., Murad M. H., Lane M., Lampropulos J. F., Albuquerque F., Mullan R. J., Agrwal N., Elamin M. B., Gallegos-Orozco J. F., Wang A. T., Erwin P. J., Bhasin S., Montori V. M., Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. Journal of Clinical Endocrinology and Metabolism 2010 95 6 2560 2575 2-s2.0-77954394453 10.1210/jc.2009-2575
7. Eckel R. H., Grundy S. M., Zimmet P. Z., The metabolic syndrome. Lancet 2005 365 9468 1415 1428 2-s2.0-17144380822 10.1016/S0140-6736(05)66378-7 (Pubitemid 40523737)
8. Fasshauer M., Paschke R., Regulation of adipocytokines and insulin resistance. Diabetologia 2003 46 12 1594 1603 2-s2.0-0348107406 10.1007/s00125-003-1228-z (Pubitemid 38005321)
9. Fain J. N., Tichansky D. S., Madan A. K., Most of the interleukin 1 receptor antagonist, cathepsin S, macrophage migration inhibitory factor, nerve growth factor, and interleukin 18 release by explants of human adipose tissue is by the non-fat cells, not by the adipocytes. Metabolism 2006 55 8 1113 1121 2-s2.0-33745699451 10.1016/j.metabol.2006.04.008
10. Weisberg S. P., McCann D., Desai M., Rosenbaum M., Leibel R. L., Ferrante A. W. Jr., Obesity is associated with macrophage accumulation in adipose tissue. Journal of Clinical Investigation 2003 112 12 1796 1808 2-s2.0-0348230958 10.1172/JCI200319246 (Pubitemid 38063703)
11. Bruun J. M., Lihn A. S., Pedersen S. B., Richelsen B., Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. Journal of Clinical Endocrinology and Metabolism 2005 90 4 2282 2289 2-s2.0-17844393870 10.1210/jc.2004-1696 (Pubitemid 40586275)
12. Dandona P., Aljada A., Ghanim H., Mohanty P., Tripathy C., Hofmeyer D., Chaudhuri A., Increased plasma concentration of macrophage Migration Inhibitory Factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin. Journal of Clinical Endocrinology and Metabolism 2004 89 10 5043 5047 2-s2.0-6344247712 10.1210/jc.2004-0436 (Pubitemid 39391446)
13. Church T. S., Willis M. S., Priest E. L., LaMonte M. J., Earnest C. P., Wilkinson W. J., Wilson D. A., Giroir B. P., Obesity, macrophage migration inhibitory factor, and weight loss. International Journal of Obesity 2005 29 6 675 681 2-s2.0-20044382686 10.1038/sj.ijo.0802942 (Pubitemid 40769489)
14. Christiansen T., Richelsen B., Bruun J. M., Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. International Journal of Obesity 2005 29 1 146 150 2-s2.0-11244302456 10.1038/sj.ijo.0802839 (Pubitemid 40065478)
15. Westerbacka J., Kolak M., Kiviluoto T., Arkkila P., Sirén J., Hamsten A., Fisher R. M., Yki-Järvinen H., Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects. Diabetes 2007 56 11 2759 2765 2-s2.0-35748972366 10.2337/db07-0156 (Pubitemid 350044919)
16. Sell H., Eckel J., Monocyte chemotactic protein-1 and its role in insulin resistance. Current Opinion in Lipidology 2007 18 3 258 262 2-s2.0-34248377344 10.1097/MOL.0b013e3281338546 (Pubitemid 46743048)
17. Herder C., Klopp N., Baumert J., Müller M., Khuseyinova N., Meisinger C., Martin S., Illig T., Koenig W., Thorand B., Effect of macrophage migration inhibitory factor (MIF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: results from the MONICA/KORA Augsburg Case-Cohort Study, 1984-2002. Diabetologia 2008 51 2 276 284 2-s2.0-37549070669 10.1007/s00125-007-0800-3
18. Nielsen T. L., Hagen C., Wraae K., Brixen K., Petersen P. H., Haug E., Larsen R., Andersen M., Visceral and subcutaneous adipose tissue assessed by magnetic resonance imaging in relation to circulating androgens, sex hormone-binding globulin, and luteinizing hormone in young men. Journal of Clinical Endocrinology and Metabolism 2007 92 7 2696 2705 2-s2.0-34447131545 10.1210/jc.2006-1847 (Pubitemid 47037378)
19. Cooper C., Dere W., Evans W., Kanis J. A., Rizzoli R., Sayer A. A., Sieber C. C., Kaufman J.-M., van Kan G. A., Boonen S., Adachi J., Mitlak B., Tsouderos Y., Rolland Y., Reginster J.-Y. L., Frailty and sarcopenia: definitions and outcome parameters. Osteoporosis International 2012 7 1839 1848 2-s2.0-84856188966 10.1007/s00198-012-1913-1
20. Isidori A. M., Giannetta E., Greco E. A., Gianfrilli D., Bonifacio V., Isidori A., Lenzi A., Fabbri A., Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis. Clinical Endocrinology 2005 63 3 280 293 2-s2.0-24144489427 10.1111/j.1365-2265. 2005.02339.x (Pubitemid 41233445)
21. Kvorning T., Christensen L. L., Madsen K., Nielsen J. L., Gejl K. D., Brixen K., Andersen M., Mechanical muscle function and lean body mass during supervised strength training and testosterone therapy in aging men with low normal testosterone levels-a placebo-controlled, randomized, double-blind study. Journal of the American Geriatrics Society 2013 61 6 957 962 10.1111/jgs.12279
22. Vermeulen A., Verdonck L., Kaufman J. M., A critical evaluation of simple methods for the estimation of free testosterone in serum. Journal of Clinical Endocrinology and Metabolism 1999 84 10 3666 3672 2-s2.0-0033305020 (Pubitemid 30645223)
23. Mosbech T. H., Pilgaard K., Vaag A., Larsen R., Automatic segmentation of abdominal adipose tissue in MRI. Lecture Notes in Computer Science 2011 6688 501 511 2-s2.0-79957505759 10.1007/978-3-642-21227-7-47
24. Corona G., Rastrelli G., Vignozzi L., Mannucci E., Maggi M., Testosterone, cardiovascular disease and the metabolic syndrome. Best Practice and Research 2011 25 2 337 353 2-s2.0-79952541665 10.1016/j.beem.2010.07.002
25. Aloisi A. M., Pari G., Ceccarelli I., Vecchi I., Ietta F., Lodi L., Paulesu L., Gender-related effects of chronic non-malignant pain and opioid therapy on plasma levels of macrophage migration inhibitory factor (MIF). Pain 2005 115 1-2 142 151 2-s2.0-17044364950 10.1016/j.pain.2005.02.019
26. Glintborg D., Andersen M., Richelsen B., Bruun J. M., Plasma monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1 are increased in patients with polycystic ovary syndrome (PCOS) and associated with adiposity, but unaffected by pioglitazone treatment. Clinical Endocrinology 2009 71 5 652 658 2-s2.0-70349696503 10.1111/j.1365-2265.2009.03523.x
27. Christiansen J. J., Bruun J. M., Christiansen J. S., Jørgensen J. O., Gravholt C. H., Long-term DHEA substitution in female adrenocortical failure, body composition, muscle function, and bone metabolism: a randomized trial. European Journal of Endocrinology 2011 165 2 293 300 2-s2.0-79960182980 10.1530/EJE-11-0289
28. Meinhardt A., Bacher M., Wennemuth G., Eickhoff R., Hedger M., Macrophage migration inhibitory factor (MIF) as a paracrine mediator in the interaction of testicular somatic cells. Andrologia 2000 32 1 46 48 2-s2.0-0033966702 (Pubitemid 30090284)
29. Charo I. F., Ransohoff R. M., Mechanisms of disease: the many roles of chemokines and chemokine receptors in inflammation. The New England Journal of Medicine 2006 354 6 610 621 2-s2.0-32144454172 10.1056/NEJMra052723 (Pubitemid 43209108)
30. Kleemann R., Bucala R., Macrophage migration inhibitory factor: critical role in obesity, insulin resistance, and associated comorbidities. Mediators of Inflammation 2010 2010 7 2-s2.0-77951907699 10.1155/2010/610479 610479
31. Bruun J. M., Helge J. W., Richelsen B., Stallknecht B., Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects. American Journal of Physiology. Endocrinology and Metabolism 2006 290 5 E961 E967 2-s2.0-33646397556 10.1152/ajpendo.00506.2005
32. Harman-Boehm I., Blüher M., Redel H., Sion-Vardy N., Ovadia S., Avinoach E., Shai I., Klöting N., Stumvoll M., Bashan N., Rudich A., Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. Journal of Clinical Endocrinology and Metabolism 2007 92 6 2240 2247 2-s2.0-34347249246 10.1210/jc.2006-1811 (Pubitemid 46997129)
33. Klein S., Fontana L., Young L., Coggan A. R., Kilo C., Patterson B. W., Mohammed B. S., Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. The New England Journal of Medicine 2004 350 25 2549 2557 2-s2.0-2942526828 10.1056/NEJMoa033179 (Pubitemid 38758542)
34. Karastergiou K., Smith S. R., Greenberg A. S., Fried S. K., Sex differences in human adipose tissues-the biology of pear shape. Biology of Sex Differences 2012 1 article 13
35. Frederiksen L., Nielsen T. L., Wraae K., Hagen C., Frystyk J., Flyvbjerg A., Brixen K., Andersen M., Subcutaneous rather than visceral adipose tissue is associated with adiponectin levels and insulin resistance in young men. Journal of Clinical Endocrinology and Metabolism 2009 94 10 4010 4015 2-s2.0-70349909882 10.1210/jc.2009-0980
36. Lucotti P., Monti L. D., Setola E., Galluccio E., Gatti R., Bosi E., Piatti P., Aerobic and resistance training effects compared to aerobic training alone in obese type 2 diabetic patients on diet treatment. Diabetes Research and Clinical Practice 2011 94 3 395 403 2-s2.0-82955232383 10.1016/j.diabres.2011. 08.002